Shiga toxin of enterohaemorrhagic Escherichia coli directly injures developing human erythrocytes

Cellular Microbiology

Volumn 18, Issue 10, 2016, Pages 1339-1348

  Betz, Josefine ^a   Dorn, Isabel ^a   Kouzel, Ivan U ^a   Bauwens, Andreas ^a   Meisen, Iris ^a   Kemper, Björn ^a   Bielaszewska, Martina ^a   Mormann, Michael ^a   Weymann, Lena ^a   Sibrowski, Walter ^a   Karch, Helge ^a   Schlenke, Peter ^a,b   Müthing, Johannes ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GLYCOSPHINGOLIPID; PROTEIN GB3CER; PROTEIN GB4CER; RECEPTOR; SHIGA TOXIN 2A; SYNTHETASE; UNCLASSIFIED DRUG; VEROTOXIN 2;

ADULT; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ERYTHROBLAST; ERYTHROCYTE; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNODETECTION; MASS SPECTROMETRY; MODEL; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84987790621     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12592     Document Type: Article

References (30)

1. Amirlak, I., and Amirlak, B. (2006) Haemolytic uraemic syndrome: an overview. Nephrology 11: 213–218.
2. Bauwens, A., Bielaszewska, M., Kemper, B., Langehanenberg, P., von Bally, G., Reichelt, R., et al. (2011) Differential cytotoxic action of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells. Thromb Haemost 105: 515–528.
3. Bauwens, A., Betz, J., Meisen, I., Kemper, B., Karch, H., and Müthing, J. (2013) Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature. Cell Mol Life Sci 70: 425–457.
4. Betz, J., Bielaszewska, M., Thies, A., Humpf, H.U., Dreisewerd, K., Karch, H., et al. (2011) Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains. J Lipid Res 52: 618–634.
5. Bielaszewska, M., Mellmann, A., Zhang, W., Köck, R., Fruth, A., Bauwens, A., et al. (2011) Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 11: 671–676.
6. Brigotti, M., Alfieri, R., Sestili, P., Bonelli, M., Petronini, P.G., Guidarelli, A., et al. (2002) Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells. FASEB J 16: 365–372.
7. Brigotti, M. (2012) The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety? Toxins 4: 157–190.
8. Chester, M.A. (1998) IUPAC-IUB joint commission on biochemical nomenclature (JCBN). Nomenclature of glycolipids -recommendations 1997. Eur J Biochem 257: 293–298.
9. Cooling, L.L., Zhang, D.S., Naides, S.J., and Koerner, T.A. (2003) Glycosphingolipid expression in acute nonlymphocytic leukemia: common expression of shiga toxin and parvovirus B19 receptors on early myeloblasts. Blood 101: 711–721.
10. Croxen, M.A., Law, R.J., Scholz, R., Keeney, K.M., Wlodarska, M., and Finlay, B.B. (2013) Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 26: 822–880.
11. Dorn, I., Klich, K., Arauzo-Bravo, M.J., Radstaak, M., Santourlidis, S., Ghanjati, F., et al. (2015) Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin. Haematologica 100: 32–41.
12. Giarratana, M.C., Kobari, L., Lapillonne, H., Chalmers, D., Kiger, L., Cynober, T., et al. (2005) Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 23: 69–74.
13. Karch, H., Tarr, P.I., and Bielaszewska, M. (2005) Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 295: 405–418.
14. Karch, H., Denamur, E., Dobrindt, U., Finlay, B.B., Hengge, R., Johannes, L., et al. (2012) The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak. EMBO Mol Med 4: 841–848.
15. Karmali, M.A. (2009) Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome. Kidney Int Suppl 75: S4–S7.
16. Kemper, B., Bauwens, A., Vollmer, A., Ketelhut, S., Langehanenberg, P., Müthing, J., et al. (2010) Label-free quantitative cell division monitoring of endothelial cells by digital holographic microscopy. J Biomed Opt 15: 036009.
17. Kouzel, I.U., Pohlentz, G., Storck, W., Radamm, L., Hoffmann, P., Bielaszewska, M., et al. (2013) Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells. J Lipid Res 54: 692–710.
18. + hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation. Blood 94: 2901–2910.
19. Maloney, M., and Lingwood, C. (2003) Synergistic effect of verotoxin and interferon-alpha on erythropoiesis. Cell Mol Biol 49: 1363–1369.
20. Meisen, I., Rosenbrück, R., Galla, H.J., Hüwel, S., Kouzel, I.U., Mormann, M., et al. (2013) Expression of Shiga toxin 2e glycosphingolipid receptors of primary porcine brain endothelial cells and toxin-mediated breakdown of the blood-brain barrier. Glycobiology 23: 745–759.
21. Melton-Celsa, A., Mohawk, K., Teel, L., and O'Brien, A. (2012) Pathogenesis of Shiga-toxin producing Escherichia coli. Curr Top Microbiol Immunol 357: 67–103.
22. Müthing, J., Meisen, I., Zhang, W., Bielaszewska, M., Mormann, M., Bauerfeind, R., et al. (2012) Promiscuous Shiga toxin 2e and its intimate relationship to Forssman. Glycobiology 22: 849–862.
23. R Core Team (2015) R: A Language and Environment for Statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/.
24. Römer, W., Berland, L., Chambon, V., Gaus, K., Windschiegl, B., Tenza, D., et al. (2007) Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature 450: 670–675.
25. Rutjes, N.W., Binnington, B.A., Smith, C.R., Maloney, M.D., and Lingwood, C.A. (2002) Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model. Kidney Int 62: 832–845.
26. Sandvig, K., Bergan, J., Dyve, A.B., Skotland, T., and Torgersen, M.L. (2010) Endocytosis and retrograde transport of Shiga toxin. Toxicon 56: 1181–1185.
27. Scheutz, F., Teel, L.D., Beutin, L., Piérard, D., Buvens, G., Karch, H., et al. (2012) Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stxs nomenclature. J Clin Microbiol 50: 2951–2963.
28. Schweppe, C.H., Bielaszewska, M., Pohlentz, G., Friedrich, A.W., Büntemeyer, H., Schmidt, M.A., et al. (2008) Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity. Glycoconj J 25: 291–304.
29. Tarr, P.I., Gordon, C.A., and Chandler, W.L. (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073–1086.
30. Wong, C.S., Mooney, J.C., Brandt, J.R., Staples, A.O., Jelacic, S., Boster, D.R., et al. (2012) Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis 55: 33–41.